GARACI, ENRICO
 Distribuzione geografica
Continente #
NA - Nord America 56.935
AS - Asia 7.669
EU - Europa 6.520
SA - Sud America 953
AF - Africa 81
Continente sconosciuto - Info sul continente non disponibili 26
OC - Oceania 16
Totale 72.200
Nazione #
US - Stati Uniti d'America 56.756
SG - Singapore 3.734
CN - Cina 1.925
UA - Ucraina 970
DE - Germania 912
IT - Italia 820
BR - Brasile 803
RU - Federazione Russa 747
FR - Francia 669
HK - Hong Kong 621
PL - Polonia 568
IE - Irlanda 541
VN - Vietnam 515
SE - Svezia 419
GB - Regno Unito 341
FI - Finlandia 279
KR - Corea 248
JP - Giappone 192
CA - Canada 102
IN - India 102
NL - Olanda 53
AR - Argentina 52
ES - Italia 50
BD - Bangladesh 45
BE - Belgio 43
MX - Messico 42
TR - Turchia 39
ID - Indonesia 38
IQ - Iraq 30
UZ - Uzbekistan 28
CL - Cile 23
EU - Europa 23
ZA - Sudafrica 23
IL - Israele 22
EC - Ecuador 21
PK - Pakistan 20
AT - Austria 18
CO - Colombia 16
IR - Iran 16
CZ - Repubblica Ceca 15
AU - Australia 14
AL - Albania 12
EG - Egitto 12
SA - Arabia Saudita 12
VE - Venezuela 12
AZ - Azerbaigian 11
PH - Filippine 11
PY - Paraguay 11
CH - Svizzera 9
MA - Marocco 9
DZ - Algeria 8
DK - Danimarca 7
JO - Giordania 7
PE - Perù 7
TN - Tunisia 7
KE - Kenya 6
KG - Kirghizistan 6
LT - Lituania 6
TH - Thailandia 6
AE - Emirati Arabi Uniti 5
JM - Giamaica 5
NP - Nepal 5
SK - Slovacchia (Repubblica Slovacca) 5
UY - Uruguay 5
GR - Grecia 4
HN - Honduras 4
MD - Moldavia 4
NI - Nicaragua 4
PS - Palestinian Territory 4
PT - Portogallo 4
RS - Serbia 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BB - Barbados 3
CR - Costa Rica 3
DM - Dominica 3
KZ - Kazakistan 3
LB - Libano 3
MT - Malta 3
MY - Malesia 3
OM - Oman 3
TW - Taiwan 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
BS - Bahamas 2
CI - Costa d'Avorio 2
DO - Repubblica Dominicana 2
HR - Croazia 2
LV - Lettonia 2
NG - Nigeria 2
NO - Norvegia 2
PA - Panama 2
PR - Porto Rico 2
RO - Romania 2
SC - Seychelles 2
SN - Senegal 2
SY - Repubblica araba siriana 2
BF - Burkina Faso 1
BH - Bahrain 1
BN - Brunei Darussalam 1
Totale 72.172
Città #
Woodbridge 16.755
Wilmington 14.010
Houston 13.037
Ann Arbor 1.823
Singapore 1.554
Fairfield 1.233
Ashburn 969
Chandler 947
Jacksonville 893
San Jose 659
Hong Kong 618
Beijing 580
Dublin 536
Kraków 522
Seattle 493
Zhengzhou 483
Cambridge 423
Medford 416
Dearborn 336
Rome 260
Santa Clara 250
The Dalles 244
Dallas 198
Lawrence 191
Los Angeles 185
New York 168
Tokyo 162
Council Bluffs 159
Ho Chi Minh City 153
Mülheim 152
Hanoi 134
Buffalo 124
Shanghai 121
Moscow 107
Menlo Park 86
Boardman 85
Hangzhou 84
San Diego 83
Milan 79
Helsinki 66
Lauterbourg 61
San Mateo 60
Falls Church 56
São Paulo 56
Frankfurt am Main 54
Munich 51
Chicago 46
Porto Alegre 43
Toronto 42
University Park 41
Brussels 40
London 39
Mountain View 39
Guangzhou 38
Orem 38
Columbus 33
Hefei 33
Nanjing 33
Redwood City 33
Warsaw 33
Montreal 31
Norwalk 27
Verona 27
Denver 26
Rio de Janeiro 26
Kunming 25
Palo Alto 25
Brooklyn 24
Belo Horizonte 23
Haiphong 23
North Bergen 22
Turku 22
Chennai 21
Da Nang 21
Atlanta 20
Yongsan-gu 19
Jakarta 18
Phoenix 18
Stockholm 18
Amsterdam 17
Detroit 17
Saint Petersburg 17
Curitiba 15
Auburn Hills 14
Nuremberg 14
Nürnberg 14
San Francisco 14
Baghdad 13
Brno 13
Nanchang 13
Redondo Beach 13
Washington 13
Brasília 12
Jinan 12
Poplar 12
Portici 12
Salt Lake City 12
Ankara 11
Cairo 11
City of London 11
Totale 60.963
Nome #
Thymosin α1 inserts N terminus into model membranes assuming a helical conformation 641
Thymosin alpha 1: from bench to bedside 627
Combination treatment with zidovudine, thymosin alpha 1 and interferon-alpha in human immunodeficiency virus infection. 586
Influence of cocaine on murine immune surveillance. 579
Use of thymosin alpha 1 for the preparation of a medicament for the prevention and treatment of allergies 576
Synergistic effect of thymosin alpha 1 and alpha beta-interferon on NK activity in tumor-bearing mice 567
Thymosin alpha1 activates dendritic cell tryptophan catabolism and establishes a regulatory environment for balance of inflammation and tolerance 552
Thymosin alpha 1 potentiates interleukin 2-induced cytotoxic activity in mice 540
Historical review on thymosin α1 in oncology: preclinical and clinical experiences 539
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 539
Thymosin alpha(1) in combination with cytokines and chemotherapy for the treatment of cancer 538
A randomized controlled study for the evaluation of the activity of a triple combination of zidovudine, thymosin-alpha(1) and interferon-alpha in HIV-infected individuals with CD4 counts between 200 and 500 cells/mm(3) 537
Vaccination with a synthetic nonapeptide expressed in human tumors prevents colorectal cancer liver metastases in syngeneic rats 532
Thymosin α1 Interacts with Exposed Phosphatidylserine in Membrane Models and in Cells and Uses Serum Albumin as a Carrier 507
Influenza A virus replication is dependent on an antioxidant pathway that involves GSH and Bcl-2 504
Antitumour effect of OM-174 and cyclophosphamide on murine B16 melanoma in different experimental conditions 504
Effect of combined alpha IFN and prostaglandin A(1) treatment on vesicular stomatitis virus replication and heat shock protein synthesis in epithelial cells 503
ANTITUMOR EFFECT OF COMBINED TREATMENT WITH THYMOSIN ALPHA-1 AND INTERLEUKIN-2 AFTER 5-FLUOROURACIL IN LIVER METASTASES FROM COLORECTAL-CANCER IN RATS 502
Effects of cocaine administration to influenza virus-immunized mice on cytokine profiles of individual splenic CD4(+) and CD8(+) T cells 502
Transcription profile of human lymphocytes following in vitro treatment with thymosin alpha-1 498
Analisi dell’espressione di retrovirus endogeni umani (HERV) in linfomonociti di soggetti sani di varie eta’: indicazioni per un possibile ruolo nello sviluppo 497
Imbalance in corneal redox state during herpes simplex virus 1-induced keratitis in rabbits. Effectiveness of exogenous glutathione supply 496
Thymosin α1 inserts N terminus into model membranes assuming a helical conformation 496
Fluconazole resistance in Candida albicans: a review of mechanisms. 494
Antiviral activity of cyclopentenone prostaglandins: Block of virus protein synthesis and induction of stress proteins in polarized monkey kidney cells 491
activation of human endogenous retrovirus k and cellular modifications in human melanoma cell line: gene expression analysis 488
Human endogenous retroviruses and ADHD 487
Combination low-dose lymphoblastoid interferon and thymosin alpha(1) therapy in the treatment of chronic hepatitis B 485
Fluconazole resistance in Candida albicans: A review of mechanisms 483
Thymosin α 1 potentiates the release by CD8(+) cells of soluble factors able to inhibit HIV-1 and human T lymphotropic virus 1 infection in vitro 483
Intracellular GSH content and HIV replication in human macrophages 482
Correlation between induction of lymphocyte apoptosis and prostaglandin E2 production by macrophages infected with HIV 482
Inhibition of NF-κB activation sensitizes U937 cells to 3'-azido-3'-deoxythymidine induced apoptosis. 482
Activation of human endogenous retrovirus k (herv-k) and cellular modifications in a human melanoma cell line: trascriptional profiling analysis 481
Thymosin alpha 1 and HIV-1: Recent advances and future perspectives 481
Combination therapy in the treatment of chronic viral hepatitis and prevention of hepatocellular carcinoma 477
Inhibition of influenza A virus replication by resveratrol 477
Red blood cells mediated delivery of 9-(2-phosphonylmethoxyethyl)adenine to primary macrophages: Efficiency, metabolism and activity against human immunodeficiency virus or herpes simplex virus 475
Differential effects of acute morphine administrations on polymorphonuclear cell metabolism in various mouse strains 474
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 474
Effect of acute or daily cocaine administration on cellular immune response and virus infection in mice 473
Ruolo eziopatogenetico dei retrovirus endogeni umani: il caso del melanoma 468
Nerve growth factor is an autocrine factor essential for the survival of macrophages infected with HIV 467
Macrophages and HIV infection: Therapeutical approaches toward this strategic virus reservoir 465
Glutathione inhibits HIV replication by acting at late stages of the virus life cycle 465
Detection of high levels of Survivin-immunoglobulin M immune complex in sera from hepatitis C virus infected patients with cirrhosis 464
Herpesviruses and periodontal disease: a cautionary tale 464
TCTP is a critical survival factor that protects cancer cells from oxidative stress-induced cell-death. 463
INHIBITION OF RAT FIBROBLAST CELL-PROLIFERATION AT SPECIFIC CELL-CYCLE STAGES BY COCAINE 462
Combined treatment with thymosin-alpha 1 and low dose interferon-alpha after dacarbazine in advanced melanoma 462
Effects of in vivo PGE2 administration on IL 2 production by splenocytes collected from normal and tumor-bearing mice . vol. 2, p. 31-40 462
Adhd and human endogenous retroviruses 460
PCT (WO/2006/069812) RETROTRANSPOSON INHIBITION IN THERAPY 459
Activation of human endogenous retrovirus K (HERV-K) and cellular modifications in human melanoma cell line: transcriptional profiling analysis 458
Anti-nerve growth factor Ab abrogates macrophage-mediated HIV-1 infection and depletion of CD4+ T lymphocytes in hu-SCID mice 457
Drug-loaded red blood cell-mediated clearance of HIV-1 macrophage reservoir by selective inhibition of STAT1 expression 456
Cocaine potentiates the switch between latency and replication of Epstein-Barr virus in Raji cells. 455
ACTIVATION OF HUMAN ENDOGENOUS RETROVIRUS K AND CELLULAR MODIFICATIONS IN HUMAN MELANOMA CELL LINE: GENE EXPRESSION ANALYSIS. 455
Interleukin 4 stimulates infection and temporary growth of human neonatal lymphocytes exposed in vitro to human T-lymphotropic virus type I, but fails to substitute for interleukin 2 in the immortalization of infected cultures 451
Anti-tumour immunogens and vaccines 450
Effect of thymosin alpha 1 on cocaine-induced inhibition of T cell dependent murine immune response. 448
In vivo recovery of natural killer cell activity by the association of thymosin α1 and cytokines during cocaine administration 446
Analisi filogenetica di un isolato di herv-k ottenuto da una lesione di melanoma metastatico umano. 446
Combination low-dose lymphoblastoid interferon and thymosin α1 therapy in the treatment of chronic hepatitis B 442
Depressed T-cell proliferation and polymorphonuclear superoxide anion production in mice treated with cocaine 442
Treatment of aspergillus infection with thymosin alpha 1 442
Inhibition of endogenous reverse transcriptase antagonizes human tumor growth 440
Induction of apoptosis in thymocytes by prostaglandin E2 in vivo 440
New studies about the insertion mechanism of Thymosin α1 in negative regions of model membranes as starting point of the bioactivity 438
Thymosin α1 and cancer: action on immune effector and tumor target cells 437
Differential expression of a new tumor-associated antigen, TLP, during human colorectal cancer tumorigenesis 436
Cocaine effects on cell-cycle progression. 434
Studies on the induction of human lymphocyte apoptosis by prostaglandin-E2 431
Thymosin alpha 1 activates dendritic cells for antifungal Th1 resistance through Toll-like receptor signaling 430
Modulatory role of PGE2 on IL-2 production after in vivo treatment. 430
INFLUENZA DEL MICROAMBIENTE SULLA PLASTICITA’ DI CELLULE DI MELANOMA ESPRIMENTI HERV-K. 429
Thymosin-alpha 1 regulates MHC class I expression in FRTL-5 cells at transcriptional level 428
Effect of di-M-PGE2 on T cell differentiation. Flow cytometry study at thymus level 427
Combination therapy with BRMs in cancer and infectious diseases 427
Inibitori Delle Istone Deacetilasi Riattivano Il Retrovirus Endogeno Umano-K In Cellule Di Melanoma Umano 427
The activation of human endogenous retrovirus K (HERV-K) is implicated in melanoma cell malignant transformation 425
Azione antivirale delle prostaglandine: blocco della sintesi delle proteine virali ed induzione di proteine da stress in cellule di mammifero. 423
Interferon-lambda in immunocompetent individuals with a history of recurrent herpes labialis 422
Correlation between the effects of prostaglandins and interferon on B-16 melanoma growth and their modulation on natural killer activity 420
Thymosin alpha 1 in the treatment of cancer: from basic research to clinical application 420
Cidofovir on HHV-8 in BCBL-1 cells 419
Thymosin αlpha1 potentiatesthe release of antiviral factors by cd8+ cells: new tools for antiviral therapy 419
Studio sulla relazione esistente tra Nerve growth factor (NGF), infezione da Herpesvirus umano 8 (HHV-8 o KSHV) e patologie HHV-8-correlate. 419
Combination thymosin alpha(1) and lymphoblastoid interferon treatment in chronic hepatitis C 418
Effect of PGE2 on c-Myc and Bcl-2 production and programmed cell death in human lymphocytes. 418
Loss of GSH, oxidative stress, and decrease of intracellular pH as sequential steps in viral infection 415
Sequential chemoimmunotherapy for advanced non-small cell lung cancer using cisplatin, etoposide, thymosin-alpha 1 and interferon-alpha 2a 415
Modifications in spleen lymphocyte subsets after cyclophosphamide and 16,16-dimethyl prostaglandin E2 administration in mice 415
MiR-34a regulates cell proliferation, morphology and function of newborn neurons resulting in improved behavioural outcomes 411
Downregulation of thymosin beta4 in neural progenitor grafts promotes spinal cord regeneration 410
comparative cellular signal patway analysis of metastatic colorectal cancer in human and preclinical animal model 409
Human Endogenous Retroviruses-K (HERV-K) expression correlates with stemness features in melanoma cells. 408
A role for endogenous reverse transcriptase in tumorigenesis and as a target in differentiating cancer therapy 407
Thymosin alpha1 activates the TLR9/MyD88/IRF7-dependent murine cytomegalovirus sensing for induction of anti-viral responses in vivo 406
Retrotransposon inhibition in therapy 405
Totale 46.798
Categoria #
all - tutte 153.081
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 153.081


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021515 0 0 0 0 0 0 0 0 0 0 396 119
2021/20221.893 49 200 126 101 57 200 76 79 147 172 84 602
2022/20232.651 242 166 79 384 258 600 185 156 212 13 271 85
2023/2024837 105 30 65 33 83 147 103 59 16 17 18 161
2024/20255.550 169 961 573 303 155 338 344 274 458 359 897 719
2025/20266.655 589 335 861 581 568 216 735 979 889 890 12 0
Totale 72.554